反应详情

Methyl (1R,2R)-2-{[4′-(1H-benzimidazol-2-ylamino)-3′-fluoro-1,1′-biphenyl-4-yl]-carbonyl}cyclopentanecarboxylate (100 mg, 0.22 mmol) was dissolved in methanol and treated with an excess of 1 N aqueous sodium hydroxide solution (2.19 mL, 2.19 mmol). The solution was stirred at rt for 1 h, and then was concentrated under reduced pressure. The residue was partitioned between water and ethyl acetate, and the aqueous layer was adjusted to pH 2 by the addition of 1 N aqueous HCl. The organic layer was separated, washed with brine, dried (MgSO4), and concentrated under reduced pressure to provide an orange oil. The oil was suspended in THF and stirred until a precipitate formed. The precipitate was collected by filtration and washed with additional THF to provide the title compound as a yellow solid (30 mg, 31%, 80% ee). 1H NMR (300 MHz, DMSO-d6) δ 13.12 (br s, 1H), 11.30 (br s, 1H), 8.12 (d, 2H), 7.96-7.76 (m, 5H), 7.46-7.42 (m, 2H), 7.30-7.26 (m, 2H), 4.15-4.07 (m, 1H), 3.27-3.19 (m, 1H), 2.21-2.12 (m, 1H), 2.05-1.96 (m, 1H), 1.86-1.55 (m, 4H); LC-MS m/z 444.4 (MH+), retention time 2.79 minutes.

1. concentrationwas concentrated under reduced pressure
2. customThe residue was partitioned between water and ethyl acetate
3. additionthe aqueous layer was adjusted to pH 2 by the addition of 1 N aqueous HCl
4. customThe organic layer was separated
5. washwashed with brine
6. dry with materialdried (MgSO4)
7. concentrationconcentrated under reduced pressure
8. customto provide an orange oil
9. stirringstirred until a precipitate
10. customformed
11. filtrationThe precipitate was collected by filtration
12. washwashed with additional THF